Yusheng Wang
- Molecular Biology
- Cancer Research top 10%
- Ophthalmology top 5%
- Oncology
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Jie ZhuYan-Nian HuiWei ZhaoJian ZhangXiumei YangPeter WiedemannJianfeng XuDake Chu
- Topics
- Cancer-related molecular mechanisms research (8 papers)MicroRNA in disease regulation (6 papers)Angiogenesis and VEGF in Cancer (5 papers)
- Journals
- International Journal of PharmaceuticsInvestigative Ophthalmology & Visual SciencePowder Technology
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Yusheng Wang
33 papers receiving 523 citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 276
- Cancer Research 200
- Ophthalmology 135
- Oncology 61
- Radiology, Nuclear Medicine and Imaging 58
Countries citing papers authored by Yusheng Wang
This map shows the geographic impact of Yusheng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusheng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusheng Wang more than expected).
Fields of papers citing papers by Yusheng Wang
This network shows the impact of papers produced by Yusheng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusheng Wang. The network helps show where Yusheng Wang may publish in the future.
Co-authorship network of co-authors of Yusheng Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Yusheng Wang. A scholar is included among the top collaborators of Yusheng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusheng Wang. Yusheng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 3 | |
| 7 | Visualized machine learning models combined with propensity score matching analysis in single PR-positive breast cancer prognosis: a multicenter population-based study | 4 |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 5 | |
| 11 | 7 | |
| 12 | 20 | |
| 13 | 14 | |
| 14 | 4 | |
| 15 | 24 | |
| 16 | 12 | |
| 17 | 6 | |
| 18 | 37 | |
| 19 | 14 | |
| 20 | 33 |
About Yusheng Wang
Yusheng Wang is a scholar working on Cancer Research, Otorhinolaryngology and Oncology, having authored 36 papers that have together received 527 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (6 papers) and Angiogenesis and VEGF in Cancer (5 papers). The work is most often cited by research in Ophthalmology (135 citations), Cancer Research (200 citations) and Molecular Biology (276 citations). Yusheng Wang has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Jie Zhu, Yan-Nian Hui, Wei Zhao, Jian Zhang, Xiumei Yang, Peter Wiedemann, Jianfeng Xu, Dake Chu, Yan Li and Jian Zhou. Their work appears in journals such as International Journal of Pharmaceutics, Investigative Ophthalmology & Visual Science and Powder Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.